1. Home
  2. WFC vs MRK Comparison

WFC vs MRK Comparison

Compare WFC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wells Fargo & Company

WFC

Wells Fargo & Company

HOLD

Current Price

$78.04

Market Cap

224.7B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$115.27

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFC
MRK
Founded
1852
2000
Country
United States
United States
Employees
200999
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.7B
268.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
WFC
MRK
Price
$78.04
$115.27
Analyst Decision
Buy
Buy
Analyst Count
18
17
Target Price
$96.59
$125.59
AVG Volume (30 Days)
13.5M
6.7M
Earning Date
04-14-2026
04-30-2026
Dividend Yield
2.21%
3.06%
EPS Growth
N/A
8.01
EPS
N/A
N/A
Revenue
N/A
$65,011,000,000.00
Revenue This Year
$11.08
$3.61
Revenue Next Year
$4.76
$5.41
P/E Ratio
$14.15
N/A
Revenue Growth
N/A
1.31
52 Week Low
$71.93
$76.66
52 Week High
$97.76
$125.14

Technical Indicators

Market Signals
Indicator
WFC
MRK
Relative Strength Index (RSI) 51.64 48.69
Support Level $76.93 $112.49
Resistance Level $79.72 $124.09
Average True Range (ATR) 1.55 2.58
MACD 0.46 0.27
Stochastic Oscillator 86.89 34.37

Price Performance

Historical Comparison
WFC
MRK

About WFC Wells Fargo & Company

Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: